TD Cowen raised the firm’s price target on Vital Farms (VITL) to $48 from $42 and keeps a Buy rating on the shares. The firm said its Q2 results comfortably beat expectations and management raised 2025 guidance meaningfully above consensus. Strong consumer elasticity to higher egg pricing, distribution gains at retail, and supply chain execution reinforced their positive thesis on the stock.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VITL:
- Vital Farms price target raised to $48 from $41 at Morgan Stanley
- Vital Farms price target raised to $50 from $44 at BMO Capital
- Vital Farms: Strong Market Performance and Strategic Growth Drive Buy Rating
- Vital Farms Reports Strong Q2 2025 Growth
- Vital Farms’ Strong Q2 Performance and Raised 2025 Guidance Justify Buy Rating